NCT00742105 Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan Status TERMINATED Phase PHASE1
NCT00742027 Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00741377 A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients Status COMPLETED Phase PHASE1
NCT00740129 Re-treatment of Participants With Paget's Disease Using Zoledronic Acid Status COMPLETED Phase PHASE4
NCT00739973 Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension Status COMPLETED Phase PHASE3
NCT00739596 Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans Status COMPLETED Phase PHASE4
NCT00739414 Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00738387 A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00738257 A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients. Status COMPLETED Phase PHASE4
NCT00732888 Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00732784 Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00731692 This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. Status TERMINATED Phase PHASE3
NCT00731224 Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. Status COMPLETED Phase PHASE4
NCT00728351 Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) Status COMPLETED Phase PHASE3
NCT00720941 Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT00719264 Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Status COMPLETED Phase PHASE2
NCT00718861 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs Status COMPLETED Phase PHASE3
NCT00718562 Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib Status COMPLETED Phase PHASE2
NCT00715182 A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer Status COMPLETED Phase PHASE1
NCT00713284 Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic Status COMPLETED Phase PHASE4